Lianbio

ACTIVE

C/O International Corporation Services Ltd, George Town, Grand Cayman, United Stateswww.lianbio.comPublic$34.5M

Also known as:

LIAN

lianbio llc

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

42.9%

Phase 2

28.6%

Phase 3

28.6%

Trial Status Distribution

Active, not recruiting

14.3%

Completed

28.6%

Terminated

42.9%

Unknown

14.3%

Clinical Trials

Trials sponsored by this organization (7)

Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma

Phase 2

Terminated

interventional

Oct 20236 participants

BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations

Phase 1

Terminated

interventional

Jul 20234 participants

Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Phase 3

Completed

interventional

Oct 2022163 participants

Phase I Study of the BBP-398 in Patients With Advance Solid Tumors

Phase 1

Terminated

interventional

Oct 20227 participants

A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM

Phase 3

Active, not recruiting

interventional

Jan 202281 participants

Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects

Phase 1

Completed

interventional

Oct 202145 participants

Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Phase 2

Unknown

interventional

May 202080 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations